日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Olutasidenib for mutated IDH1 acute myeloid leukemia: final five-year results from the phase 2 pivotal cohort

Olutasidenib治疗IDH1突变型急性髓系白血病:II期关键队列的五年最终结果

Cortes, Jorge; Curti, Antonio; Fenaux, Pierre; Jonas, Brian A; Krauter, Jürgen; Montesinos, Pau; Récher, Christian; Taussig, David C; Wang, Eunice S; Watts, Justin; Wei, Andrew; Yee, Karen Wl; Tian, Hua; Sheppard, Aaron; Marzac, Christophe; de Botton, Stephane

Chronic hepatitis B virus infection increases the risk of kidney disease while antiviral therapy for hepatitis B virus can decrease kidney disease risk

慢性乙型肝炎病毒感染会增加肾脏疾病的风险,而乙型肝炎病毒抗病毒治疗可以降低肾脏疾病的风险。

Ito, Kaori L; Zhang, Yuqing; Li, Biao; King, Andrew; Yee, Leland J; Frenette, Catherine; Abramov, Frida; Flaherty, John F; Malkov, Vladislav A

Transitioning from night to day transplants: changing the transplant culture for optimisation through a province-wide quality improvement initiative

从夜间移植过渡到白天移植:通过全省范围的质量改进计划改变移植文化以实现优化

Streith, Lucas; Keenan, Sean; Punnen, Subin; Butler, Heidi; Lun, Eric; Sawka, Andrew; Yee, John; Dhingra, Vinay; Reynolds, Steve; Ryan, Kenneth; Yang, Brian; Carere, Ron; Kim, Peter

Deep mutational scanning and massively parallel kinetics of plasminogen activator inhibitor-1 functional stability to probe its latency transition

深度突变扫描和大规模并行纤溶酶原激活剂抑制剂-1功能稳定性动力学以探究其潜伏期转变

Laura M Haynes, Zachary M Huttinger, Andrew Yee, Colin A Kretz, David R Siemieniak, Daniel A Lawrence, David Ginsburg

High levels of von Willebrand factor with reduced specific activities in hospitalized patients with or without COVID-19

住院患者(无论是否感染 COVID-19)中血管性血友病因子水平较高且特异性活动性降低

Monica Bray, Melda A Guzel, Fong Lam, Andrew Yee, Miguel A Cruz, Rolando E Rumbaut

Phage display broadly identifies inhibitor-reactive regions in von Willebrand factor

噬菌体展示广泛识别了血管性血友病因子中的抑制剂反应区域

Andrew Yee, Manhong Dai, Stacy E Croteau, Jordan A Shavit, Steven W Pipe, David Siemieniak, Fan Meng, David Ginsburg

The Flow Dependent Adhesion of von Willebrand Factor (VWF)-A1 Functionalized Nanoparticles in an in Vitro Coronary Stenosis Model

血管性血友病因子 (VWF)-A1 功能化纳米粒子在体外冠状动脉狭窄模型中的流动依赖性粘附

Yathreb Asaad, Mark Epshtein, Andrew Yee, Netanel Korin

CpaA Is a Glycan-Specific Adamalysin-like Protease Secreted by Acinetobacter baumannii That Inactivates Coagulation Factor XII

CpaA 是一种由鲍曼不动杆菌分泌的聚糖特异性 Adamalysin 样蛋白酶,可灭活凝血因子 XII

Ursula Waack, Mark Warnock, Andrew Yee, Zachary Huttinger, Sara Smith, Ayush Kumar, Alban Deroux, David Ginsburg, Harry L T Mobley, Daniel A Lawrence, Maria Sandkvist0

High throughput protease profiling comprehensively defines active site specificity for thrombin and ADAMTS13

高通量蛋白酶谱分析全面定义了凝血酶和ADAMTS13的活性位点特异性

Colin A Kretz ,Kärt Tomberg ,Alexander Van Esbroeck ,Andrew Yee ,David Ginsburg

APC conditional knock-out mouse is a model of infantile spasms with elevated neuronal β-catenin levels, neonatal spasms, and chronic seizures

APC条件性敲除小鼠是婴儿痉挛症的模型,其特征是神经元β-catenin水平升高、新生儿痉挛和慢性癫痫发作。

Pirone, Antonella; Alexander, Jonathan; Lau, Lauren A; Hampton, David; Zayachkivsky, Andrew; Yee, Amy; Yee, Audrey; Jacob, Michele H; Dulla, Chris G